Related Experiment Video
Updated: Aug 9, 2026
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells
Elisabeth M Chalovich1, Jian-hui Zhu, John Caltagarone
1Department of Pathology, Division of Neuropathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Abstract:
Impaired survival signaling may represent a central mechanism in neurodegeneration. 6-Hydroxydopamine (6-OHDA) is an oxidative neurotoxin used to injure catecholaminergic cells of the central and peripheral nervous systems. Although 6-OHDA elicits phosphorylation of several kinases, downstream transcriptional effects that influence neuronal cell death are less defined. The cAMP response element (CRE) is present in the promoter sequences of several important neuronal survival factors. Treatment of catecholaminergic neuronal cell lines (B65 and SH-SY5Y) with 6-OHDA resulted in repression of basal CRE transactivation. Message levels of CRE-driven genes such as brain-derived neurotrophic factor and the survival factor Bcl-2 were decreased in 6-OHDA-treated cells, but message levels of genes lacking CRE sequences were not affected. Repression of CRE could be reversed by delayed treatment with cAMP several hours after initiation of 6-OHDA injury. Furthermore, restoration of CRE-driven transcription was associated with significant neuroprotection. In contrast to observations in other model systems, the mechanism of CRE repression did not involve decreased phosphorylation of its binding protein CREB. Instead, total CREB and phospho-CREB (pCREB) were increased in the cytoplasm and decreased in the nucleus of 6-OHDA-treated cells. 6-OHDA also decreased nuclear pCREB in dopaminergic neurons of primary mouse midbrain cultures. Co-treatment with cAMP promoted/restored nuclear localization of pCREB in both immortalized and primary culture systems. Increased cytoplasmic pCREB was observed in degenerating human Parkinson/Lewy body disease substantia nigra neurons but not in age-matched controls. Notably, cytoplasmic accumulation of activated upstream CREB kinases has been observed previously in both 6-OHDA-treated cells and degenerating human neurons, supporting a potential role for impaired nuclear import of phosphorylated signaling proteins.
Insights
Neurotoxin 6-Hydroxydopamine (6-OHDA) impairs neuronal survival by disrupting cAMP response element (CRE) signaling. Restoring CRE activity with cAMP protects against 6-OHDA-induced neurodegeneration.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Impaired neuronal survival signaling is implicated in neurodegeneration.
- 6-Hydroxydopamine (6-OHDA) is a neurotoxin that injures catecholaminergic cells.
- The role of downstream transcriptional effects of 6-OHDA on neuronal cell death is not fully understood.
Purpose of the Study:
- To investigate the impact of 6-OHDA on cAMP response element (CRE) transactivation and its downstream effects on neuronal survival.
- To explore the mechanism by which 6-OHDA represses CRE activity.
- To determine if restoring CRE activity can protect against 6-OHDA-induced neurotoxicity.
Main Methods:
- Catecholaminergic neuronal cell lines (B65, SH-SY5Y) and primary mouse midbrain cultures were treated with 6-OHDA.
- CRE transactivation, message levels of CRE-driven genes (BDNF, Bcl-2), and CRE-binding protein (CREB) localization were assessed.
- Delayed treatment with cAMP was used to investigate neuroprotection and CRE restoration.
Main Results:
- 6-OHDA treatment repressed basal CRE transactivation and decreased message levels of CRE-driven survival genes.
- Repression of CRE was reversed by delayed cAMP treatment, leading to significant neuroprotection.
- 6-OHDA caused cytoplasmic accumulation and decreased nuclear localization of phospho-CREB (pCREB), a mechanism distinct from altered CREB phosphorylation.
- pCREB mislocalization was observed in 6-OHDA-treated cells and in human Parkinson's disease substantia nigra neurons.
Conclusions:
- 6-OHDA-induced neurodegeneration involves the repression of CRE-driven transcription.
- Impaired nuclear import of pCREB is a key mechanism in 6-OHDA neurotoxicity.
- Restoring CRE-driven transcription via cAMP treatment offers a potential therapeutic strategy for neuroprotection in conditions like Parkinson's disease.
